Back

Non-vitamin K oral anticoagulants in valvular heart disease before surgery: a tale of bridging vs. no bridging

European Heart Journal

8 October 2024
Organised by: Logo
Read full article
ESC Journals CARDIOVASCULAR PHARMACOLOGY OTHER European Society of Cardiology VALVULAR, MYOCARDIAL, PERICARDIAL, PULMONARY, CONGENITAL HEART DISEASE Valvular Heart Disease

Contributors

Raffaele De Caterina
Raffaele De Caterina

Author

University of Pisa Pisa , Italy

Hugo ten Cate
Hugo ten Cate

Author

Maastricht University Medical Centre (MUMC) Maastricht , Netherlands (The)

Vittorio Pengo
Vittorio Pengo

Author

Padova University Hospital Padua , Italy

You may be interested in
thumbnail
Congress Presentation
Perioperative management of antithrombotic therapy.
29 August 2022
thumbnail
Congress Presentation
Meta-analysis on the comparison of direct oral anticoagulants versus vitamin k antagonists after transcatheter aortic valve implantation in patients with pre-existing atrial fibrillation
26 August 2022
thumbnail
Congress Session
Failing valves and beyond
19 May 2025
thumbnail
Congress Presentation
Oral anticoagulation in 13,344 adult patients with congenital heart disease (ACHD) in a longitudinal real-world setting in 2005-2017
2 September 2019

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources